You are here: Industry Insights > sales

News List

Sanofi profits and sales fall in Q2 pharmatimes
August 01, 2018
Sanofi saw its profits and sales fall in Q2 in the wake of several high-profile exclusivity losses.
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report fiercepharma
June 13, 2018
Shingrix may not make it on the top 5 best-selling vaccines list in 2024...
A Description of the Market Data of the 9 Marketed Biosimilars in the U.S. Dopine
May 28, 2018
The marketing of many biosimilars has met resistance in the U.S. recently as FDA sent CRLs for them.
Generic competition hits AZ’ first-quarter sales pharmatimes
May 24, 2018
The drugs giant booked revenues of $5.2 billion for the quarter, marking a 4 percent drop from a year ago, or a 9 percent decline at constant exchange rates, while core operating profit plummeted 46 percent (47 percent CER) to $896 million.
Bayer's growth-driving quintet? Better make it a trio, thanks to Stivarga and Xofigo stall fiercepharma
May 04, 2018
Bayer blamed a strong euro for some obvious weak spots in its first-quarter numbers, but that explanation just doesn't fly for its consumer health stall...
Manufacturing hiccup in China trips up Sanofi's vaccine sales momentum fiercepharma
May 02, 2018
After a strong 2017, Sanofi Pasteur got off to a less-than-stellar start this year. In China, inspectors put a temporary kibosh on imports ...
Werfen sales Increases over 13 per cent biospectrumasia
April 28, 2018
Werfen has strengthened its presence in all regions, especially in China, where sales have achieved a 21% increase against 2016. Currently, Asia-Pacific accounts for 16% of total revenues.
First-quarter sales of GlaxoSmithKline's prescription drugs fall 4 percent firstwordpharma
April 26, 2018
GlaxoSmithKline said Wednesday that first-quarter revenue from prescription drugs slipped 4 percent year-over-year to 4 billion pounds , hit by currency effects and lower sales of Seretide/Advair, Ventolin and established medicines.
Novartis Sees Sharp Decline in Generic Drug Sales During First Quarter biospace
April 20, 2018
Shares of Novartis are down nearly 3 percent this morning after the company reported a sharp decline in generic drugs and sales results from key branded medicines that missed analysts’ projections for the first quarter.
1Q2018 Earnings Call Highlights Abbott’s $7.4 Billion In Sales biospace
April 19, 2018
Abbott today announced financial results for the first quarter ending March 31, 2018. Key takeaways from this morning’s earnings call include:

Previous page 1 2 3 4 Next page